跳至主要内容
临床试验/NCT05166603
NCT05166603终止不适用

Expanding Access to Comprehensive Geriatrics Care Via Telehealth (QUE 20-010)

VA Office of Research and Development2 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2021年10月18日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
111
试验地点
2
主要终点
90-day All-cause Mortality

研究概览

简要总结

The overall objective of the TeleGRACE project is to improve the care and outcomes of older Veterans with a recent inpatient stay by expanding access to the evidence-based GRACE program, by evaluating a telehealth implementation.

详细描述

The TeleGRACE evaluation will focus on three primary aims and a secondary aim:

Primary Aim 1: To examine the effectiveness of the TeleGRACE program, the investigators designed a randomized controlled implementation trial (RCT) powered for the primary outcome of 90-day all-cause mortality. The investigators will also examine its effectiveness for the secondary outcomes including 90-day readmissions, 1-year ED utilization (VA and non-VA), 1-year all-cause readmissions, 1-year mortality, as well as patient, caregiver, and staff satisfaction. The investigators hypothesize that patients who receive TeleGRACE will have lower 90-day mortality than patients in usual care.

Primary Aim 2: to examine the implementation of the TeleGRACE program. The implementation strategy is reflecting & evaluating. Implementation outcomes are based on the REAIM framework and include reach, efficacy (Aim 1), and implementation (total number of Veterans served, fidelity).

Primary Aim 3: to conduct a business-case analysis (BCA). The business case analysis will calculate the net financial savings or loss for TeleGRACE as the difference in the overall intervention costs and savings due to downstream benefits for patients receiving TeleGRACE versus usual care controls.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Veterans discharged from the Indianapolis VA medical center (VAMC) for an medical/surgical diagnosis (excludes substance use disorder-related admissions; excludes planned admissions) within the prior week
  • Age 70 years
  • Not enrolled in home-based primary care (HBPC)
  • Not enrolled in hospice
  • Not in dialysis
  • Primary care visit within VA in the prior 2 years
  • Not residing in nursing home, skilled nursing facility, or CLC.
  • Living >20 miles but <60 miles from the Indianapolis VAMC facility
  • CAN score 95th percentile for mortality or missing CAN score
  • Discharged from the hospital alive

排除标准

  • Patients who have been randomized to the control arm after their index hospitalization who become readmitted to the hospital may not be re-randomized.
  • By definition, GRACE patients are not eligible for TeleGRACE due to the drive distance >20 miles from the Indianapolis VAMC
  • Enrolled in home-based primary care (HBPC)
  • Enrolled in hospice
  • Dialysis (hemodialysis or peritoneal dialysis)
  • Residing in nursing home, skilled nursing facility, or CLC.
  • Living <20 miles or 60 miles from the Indianapolis VAMC facility

结局指标

主要结局

90-day All-cause Mortality

时间窗: 90-days from discharge from the index hospitalization

The primary outcome is 90-day all-cause mortality measured from the date of discharge from the index hospitalization.

次要结局

未报告次要终点

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验